| PT-LPDs | Post-transplantation lymphoproliferative disorders |
|---|---|
| PRIME-MD | Primary Care Evaluation of Mental Disorders |
| SADS-L | Schedule for Affective Disorders and Schizophrenia Lifetime Version |
| SRBD | Sleep-Related Breathing Disorders |
| SCID II | Structured Clinical Interview for DSM-III-R Personality Disorders |
| substance-induced organic mental disorders | Mental disorders caused by use of drugs, e.g., cocaine. (05 Mar 2000) |
|---|---|
| substance-related disorders | These non-psychotic disorders include those related to the taking of a drug of abuse (including alcohol), to the side effects of a medication, and to toxin exposure. (12 Dec 1998) |
| delirium, dementia, amnestic, cognitive disorders | Cognitive disorders including delirium, dementia, and other cognitive disorders. These may be the result of substance use, trauma, or other causes. (12 Dec 1998) |
| disorders, myeloproliferative | Tumours of certain bone marrow cells including those that give rise to red cells, granulocytes, and platelets. As opposed to the lymphoproliferative disorders. (12 Dec 1998) |
| dissociative disorders | Sudden temporary alterations in the normally integrative functions of consciousness. (12 Dec 1998) |
| immunodeficiency disorders | <radiology> B-cell (antibody) deficiency: high-grade pathogens: pneumococcus, strep, H. Flu, chronic sinopulmonary disease, usual survival to adulthood, T-cell (cellular) deficiency: low-grade pathogens: fungi, viruses, Pneumocystic, growth retardation, diarrhoea, delayed anergy, short life-span, susceptible to graft vs. Host (GvH) disease, e.g.: DiGeorge syndrome, Nezelhof syndrome Note: increased risk of malignancy (12 Dec 1998) |
| immunoproliferative disorders | Disorders characterised by abnormal proliferation of primary cells of the immune system or by excessive production of immunoglobulins. (12 Dec 1998) |
| impulse control disorders | Disorders whose essential features are the failure to resist an impulse, drive, or temptation to perform an act that is harmful to the individual or to others. Individuals experience an increased sense of tension prior to the act and pleasure, gratification or release of tension at the time of committing the act. (12 Dec 1998) |
| infant nutrition disorders | Malnutrition, occurring in infants ages 1 month to 24 months, which is due to insufficient intake of food, dietary nutrients, or a pathophysiologic condition which prevents the absorption and utilization of food. Growth and development are markedly affected. (12 Dec 1998) |
| iron metabolism disorders | Disorders in the processing of iron in the body: its absorption, transport, storage, and utilization. (12 Dec 1998) |
| ocular motility disorders | Disorders of eye movement resulting from malfunction of the sensory-motor mechanism of the eye which leads to faulty alignment of the eyes and/or visual impairment. (12 Dec 1998) |
| oesophageal motility disorders | Disorders affecting the motor function of the upper or lower oesophageal sphincters, the oesophageal body, or a combination of these parts. The failure of the sphincters to maintain a tonic pressure may result in the impeding of the passage of food, regurgitation of food, or reflux of gastric acid into the oesophagus. (12 Dec 1998) |
| opioid-related disorders | Disorders related or resulting from abuse or mis-use of opioids. (12 Dec 1998) |
| temporomandibular joint disorders | A variety of conditions affecting the anatomic and functional characteristics of the temporomandibular joint. Factors contributing to the complexity of temporomandibular diseases are its relation to dentition and mastication and the symptomatic effects in other areas which account for referred pain to the joint and the difficulties in applying traditional diagnostic procedures to temporomandibular joint pathology where tissue is rarely obtained and X-rays are often inadequate or non-specific. Common diseases are developmental abnormalities, trauma, subluxation, luxation, arthritis, and neoplasia. (12 Dec 1998) |
| eating disorders | A group of disorders characterised by physiological and psychological disturbances in appetite or food intake. (12 Dec 1998) |